Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EU-C-001 in moderate to severe traumatic brain injury
2017-004890-15Phase 2Unknown
- Sponsor
- Eustralis Pharmaceuticals
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EU-C-001 in traumatic brain injury (TBI) (3 arms), sponsored by Eustralis Pharmaceuticals. Primary endpoint: Intracranial pressure AUEC over 0 to 48 hours. Status: unknown.
02
Drugs
EU-C-001
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2017-004890-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004890-15.